Literature DB >> 1725149

Direct and indirect pathogenicity of beta-lactamase-producing bacteria in respiratory tract infection in children. Role of cephalosporins resistant to enzymatic hydrolysis.

S Stefani1, M B Pellegrino, G Russo, G Nicoletti.   

Abstract

A recent increase in the incidence of beta-lactamase-producing aerobic and anaerobic bacteria in upper respiratory tract infection has been associated with an increase in the failure rate of penicillin treatment of these infections. Experimental evidence for this correlation has been reported by many investigators, who have described the sheltering of susceptible pathogens by beta-lactamase-producing organisms as 'indirect pathogenicity'. The organisms implicated in mixed infections that cooperate are Staphylococcus aureus, Haemophilus influenzae, Branhamella (Moraxella) catarrhalis and Bacteroides spp., which are pathogenic and also normal oropharyngeal inhabitants. Since these bacteria exhibit both direct and indirect pathogenicity, effective treatment requires administration of antimicrobial therapy active against all microorganisms present in mixed infection. Oral third generation cephalosporins, which are resistant to enzymatic hydrolysis, seem to be suitable initial therapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1725149     DOI: 10.2165/00003495-199100424-00006

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  14 in total

1.  THE ROLE OF PENICILLINASE IN STAPHYLOCOCCAL INFECTIONS.

Authors:  M SHILO; N CITRI
Journal:  Br J Exp Pathol       Date:  1964-04

2.  Beta-lactamase: lessons in the art of survival.

Authors:  N Citri
Journal:  J Chemother       Date:  1991-04       Impact factor: 1.714

3.  "Indirect pathogenicity" of penicillinase-producing enterobacteria in chronic bronchial infections.

Authors:  J L Maddocks; J R May
Journal:  Lancet       Date:  1969-04-19       Impact factor: 79.321

4.  Efficacy of beta-lactamase-resistant penicillin and influence of penicillin tolerance in eradicating streptococci from the pharynx after failure of penicillin therapy for group A streptococcal pharyngitis.

Authors:  T D Smith; W C Huskins; K S Kim; E L Kaplan
Journal:  J Pediatr       Date:  1987-05       Impact factor: 4.406

5.  New cause of penicillin treatment failure.

Authors:  P Barnes; P M Waterworth
Journal:  Br Med J       Date:  1977-04-16

6.  In-vivo protection of group A beta-haemolytic streptococci from penicillin by beta-lactamase-producing Bacteroides species.

Authors:  I Brook; G Pazzaglia; J C Coolbaugh; R I Walker
Journal:  J Antimicrob Chemother       Date:  1983-12       Impact factor: 5.790

7.  Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.

Authors:  C H O'Callaghan; A Morris; S M Kirby; A H Shingler
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

Review 8.  Direct and indirect pathogenicity of beta-lactamase-producing bacteria in mixed infections in children.

Authors:  I Brook
Journal:  Crit Rev Microbiol       Date:  1989       Impact factor: 7.624

Review 9.  Cefixime. A review of its antibacterial activity. Pharmacokinetic properties and therapeutic potential.

Authors:  R N Brogden; D M Campoli-Richards
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

10.  Role of beta-lactamase-producing bacteria in the failure of penicillin to eradicate group A streptococci.

Authors:  I Brook
Journal:  Pediatr Infect Dis       Date:  1985 Sep-Oct
View more
  1 in total

Review 1.  A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.